Tag:
amyotrophic lateral sclerosis
Latest Headlines
Latest Headlines
Failed ALS study haunts Biogen in lawsuit from unhappy partner
Biogen Idec has been unable to shake off Knopp Neurosciences, from which Biogen licensed a compound against Lou Gehrig's disease that fell short in a recent late-stage study.
Biogen Idec to offset tax burden for workers in same-sex relationships
Biogen Idec ($BIIB) is reaching into its own pocket to make up for a federal tax that hits its gay employees, The Boston Globe reported. Next year the biotech giant is expected to start padding the pay of homosexual staffers who are taxed, unlike their heterosexual coworkers, on health-insurance contributions for their spouses.
Biogen Idec bankrolls top academics' exploration of Lou Gehrig's disease
Today the company announced the initiative focused on amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, with plans to funnel more than $10 million over three years into projects from neuroscience experts at institutions such as Columbia University, Harvard University, Rockefeller University and Yale University.
Blood protein tags progression in ALS
In a study sponsored by the ALS Association, researchers have assessed a blood protein biomarker that could be used to track the progression of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
Neuraltus Pharma eyes PhIII after missing endpoints in trial for ALS drug
Despite falling short of goals in a Phase II trial, Neuraltus Pharmaceuticals saw enough evidence of efficacy in Lou Gehrig's disease patients on its experimental drug to push forward plans for a late-state study. Its decision to start the Phase III program next year underscores the critical need for new therapies against the muscle-disabling disorder.
Blood biomarker for ALS points to new therapy
Researchers from Brigham and Women's Hospital have found a blood biomarker that could detect amyotrophic lateral sclerosis (ALS), a progressive degenerative neurological disease that affects about 30,000 Americans.
SOD1 biomarker test in development for Lou Gehrig's disease
Take a piece of paper--folding it makes a paper plane, an envelope, a complex and delicate origami flower, or a screwed-up mess. Take a sequence of amino acids--folding it makes a functional protein,...
Neurologist wins $1M prize for ALS biomarker breakthrough
A Boston neurologist has won a $1 million prize after identifying a new biomarker for amyotrophic lateral sclerosis and developing a simple gadget that can help researchers track the progression of
